MRA General RFP

Click here to receive future RFPs

MRA 2019-2020 Request for Proposals - Now Available

The Melanoma Research Alliance (MRA) announces a Request for Proposals (RFP) soliciting high-impact pre-clinical, translational, and early clinical research from scientists and clinicians around the world. The RFP calls for ideas that have the potential to lead to near-term clinical application in melanoma prevention, detection, diagnosis, staging, and treatment. 

Proposals will be accepted for Pilot, Team Science, Young Investigator, and Mid-Career Awards. 

The Melanoma Research Alliance (MRA) announces a Request for Proposals (RFP) soliciting high-impact pre-clinical, translational, and early clinical research from scientists and clinicians around the world. The RFP calls for ideas that have the potential to lead to near-term clinical application in melanoma prevention, detection, diagnosis, staging, and treatment.

Please note that the following Special Opportunities are available:    

  • In-transit Melanoma Research Team Science Award - new!
  • Melanoma Metastasis Team Science Award, jointly sponsored by the Rising Tide Foundation for Clinical Cancer Research
  • Acral Melanoma Team Science Award,
  • Melanoma Detection or Prevention Mid-Career Investigator Award, jointly sponsored with the Dermatology Foundation (U.S. applicants only),
  • Radiation Oncology Young Investigator Award with ASTRO (U.S. applicants only), and
  • Immunotherapy Young Investigator Awards supported by Bristol Myers Squibb (BMS).

Please note the following key deadlines:

  • October 7, 2019: Team Science Award Letters of Intent Due
  • November 18, 2019: Full Proposals Due for Mid-Career, Young Investigator, and Pilot Award Applicants
  • January 10, 2020: Full Proposals Due for Invited Team Science Applicants 

All proposals are due by 5:00 pm Eastern Time. Proposals should be submitted via the proposalCENTRAL on-line application tool: https://proposalcentral.com/.

MRA 2019 - 2020 Request for Proposals - Second Release

MRA Award Terms and Conditions 


Questions: 

Tasheema Prince, MRA Scientific Program Manager  

tprince@curemelanoma.org

About Melanoma

Melanoma is a leading cause of new cancers, and more effective options for patients and those at risk are urgently needed. Recent scientific and clinical advances have provided new hope, but much work remains to be done to end suffering and death from melanoma.

Login

×